(NASDAQ: ASPI) Asp Isotopes's forecast annual revenue growth rate of 128% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 2.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.71%.
Asp Isotopes's revenue in 2025 is $8,383,354.On average, 4 Wall Street analysts forecast ASPI's revenue for 2025 to be $915,871,928, with the lowest ASPI revenue forecast at $703,945,615, and the highest ASPI revenue forecast at $1,131,234,285. On average, 4 Wall Street analysts forecast ASPI's revenue for 2026 to be $5,202,724,487, with the lowest ASPI revenue forecast at $4,562,179,422, and the highest ASPI revenue forecast at $5,823,429,170.
In 2027, ASPI is forecast to generate $11,317,884,857 in revenue, with the lowest revenue forecast at $9,780,975,726 and the highest revenue forecast at $12,821,985,313.